ST-0702

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameST-0702
Drug Alias Nameaspirin prodrug/nicotinic acid (Solvotrin)acetylsalicylic acid prodrug/nicotinic acid (Solvotrin)ST-0702
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCoagulation factor inhibitorsHydroxycarboxylic acid receptor 2 agonistsCyclooxygenases inhibitors
TargetsHydroxycarboxylic acid receptor 2CyclooxygenasesCoagulation factor
Therapy Area/IndicationsLipid Metabolism DisordersCardiovascular DiseasesColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIreland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTrinity College Dublin
China Registration ClassN/A

Develop Information

Active CompaniesSolvotrin Therapeutics Ltd
Inactive CompaniesTrinity College Dublin
Active IndicationsCardiovascular DiseasesColorectal Neoplasms
Inactive IndicationsLipid Metabolism Disorders

Other Information

ATC CodeN/A
Related LinksN/A